ERCC1 mRNA levels can predict the response of cisplatin-based concurrent chemoradiotherapy for locally advanced cervical squamous cell carcinoma

摘要：

　　Objective The purpose of this study was to investigate whether the excision repair cross-complementation group 1 (ERCC1) mRNA levels could predict treatment response of patients with locally advanced cervical squamous cell carcinoma (LACSCC) who underwent cisplatin-based concurrent chemoradiotherapy (CCCRT).Methods:A total of 60 LACSCC patients,treated with radical CCCRT from a single institution were evaluated.ERCC1 mRNA level was determined by quantitative real-time RT-PCR in pre-treatment tumor tissues.

关键词： sexcision repair cross-complementation group 1 (ERCC1) cervical squamous cell carcinoma chemoradiotherapy response

作者: Zhou-lan Bai Yan-yang Wang Hong Zhe Jian-li He Ping Hai

作者单位: Graduate School of Ningxia Medical University,Yinchuan,Ningxia,China Department of Radiation Oncology,General Hospital of Ningxia Medical University,Yinchuan,Ningxia,Chi

会议类型: 国内会议

会议名称: 中华医学会第九次全国放射肿瘤治疗学学术会议

会议地点: 北京

会议语种:英文

页码: 394-394

在线出版日期: 2012-09-14（万方平台首次上网日期，不代表论文的发表时间）